Successful treatment of hyperuricemia with low doses of recombinant urate oxidase in four patients with hematologic malignancy and tumor lysis syndrome.

Authors	M Hummel, D Buchheidt, S Reiter, J Bergmann, R Hofheinz, R Hehlmann
Journal	Leukemia (Leukemia) Vol. 17 Issue 12 Pg. 2542-4 (Dec 2003) ISSN: 0887-6924 [Print] England
PMID	14523460 (Publication Type: Case Reports, Letter)
Chemical References	Recombinant Proteins rasburicase Urate Oxidase
Topics	Adult Aged Female Humans Hyperuricemia (drug therapy, etiology) Leukemia, B-Cell (complications) Leukemia, Myeloid (complications) Lymphoma, Non-Hodgkin (complications) Male Middle Aged Precursor Cell Lymphoblastic Leukemia-Lymphoma (complications) Recombinant Proteins (therapeutic use) Urate Oxidase (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!